United Petroleum, which is facing a franchisee class action over allegedly loss-making Pie Face stores, is resisting a plaintiff law firm’s bid for “a right of veto” over the petrol giant’s communications with group members, even those not represented by the firm.
German drug maker Boehringer has prevailed in its Federal Court fight against US rival Zoetis over the validity of three patents covering pig vaccines.
Pathology giant Australian Clinical Labs has proposed a divestiture of collection centres amid competition concerns about its proposed takeover of competitor Healius, the owner of Dorevitch Pathology.
Two law firms that were able to “work cooperatively” to join their cases have been awarded carriage of a shareholder class action against mining firm Downer EDI. The judge overseeing the proceedings also approved a group costs order application that proposed a “reasonable rate” of return to the firms.
A judge has permanently stayed a class action accusing Meta and Google of breaching competition law by banning cryptocurrency ads, finding there was a potential for conflicts between the self-represented applicant, who is also funding the case, and group members.
Opal Tower engineer WSP has succeeded in claiming the costs of a class action from insurers for builder Icon, with a judge finding engineers were not excluded from the policy’s coverage for subcontractors.
Monash IVF is gearing up for a legal privilege fight as it faces new claims about the team of senior doctors and directors working on a novel testing technique at the heart of a class action, including claims that one doctor “burnt paper evidence” from a trial of the technology.
A traditional custodian has won her bid to halt seismic blasting for Woodside’s Scarborough gas project off the coast of Western Australia, in a legal challenge similar to one that put Santos’ $4.7 billion Barossa project on ice.
Sanofi has lost its bid to limit evidence from experts for Amgen in a patent dispute over a cholesterol-lowering antibody, with a judge dismissing concerns about Amgen having a majority of experts giving concurrent evidence. In an application filed at the beginning of the month, the French pharmaceutical company sought to bar Amgen from relying…
The firm and funder that ran a shareholder class action against Ardent Leisure over the 2016 Dreamworld tragedy are seeking deductions totalling more than half of the $26 million settlement reached in the case.